Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ, Inc. director Gabrielle B. Toledano reported a mix of equity compensation and share sales. She received a grant of 4,526 shares of common stock as a restricted stock unit (RSU) award, which will vest in full on the earlier of the day before the next year’s annual meeting or June 17, 2027, subject to her continued board service.
She also sold 2,757 shares of common stock in an open-market transaction at a weighted average price of $55.01 per share, with individual sale prices ranging from $53.79 to $56.63. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. Following these transactions, she directly holds 11,154 shares of IonQ common stock.
IonQ, Inc. director Kathryn K. Chou reported a restricted stock unit (RSU) award and an open-market sale of common stock. On June 17, 2026, she was granted 4,526 RSUs at no cost, vesting in full on the earlier of the day before next year’s annual meeting or June 17, 2027, subject to continued board service. On June 18, 2026, she sold 2,757 shares of common stock at a weighted average price of $55.02 per share, in multiple trades between $53.80 and $56.53, under a pre-arranged Rule 10b5-1 trading plan. After these transactions, she directly held 62,608 shares of IonQ common stock.
IonQ, Inc. director and special advisor Raymond John W reported an open-market sale of 3,815 shares of common stock on June 18, 2026 at a weighted average price of $55.01 per share. The trade was executed under a pre-arranged Rule 10b5-1 trading plan, and he continues to hold 80,148 shares directly after the transaction.
IonQ, Inc. held its 2026 Annual Meeting of Stockholders on June 16, 2026. Stockholders elected two Class II directors, Kathryn K. Chou and William F. Scannell, to serve until the 2029 annual meeting and until their successors are elected and qualified.
Stockholders also ratified the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for 2026, with 164,960,644 votes in favor. In addition, a non-binding advisory proposal approving the compensation of IonQ’s named executive officers received 45,871,221 votes for, 39,484,263 against, and 968,383 abstentions, with 80,624,504 broker non-votes.
FRANKOLA JIM reported acquisition or exercise transactions in this Form 4 filing.
IonQ, Inc. director Jim Frankola reported an equity compensation grant rather than an open-market trade. He received 4,526 shares of common stock in the form of restricted stock units, with no cash paid per share, bringing his direct holdings to 8,939 shares after the award.
The RSUs vest in full on the earlier of the day before IonQ’s following year Annual Meeting or June 17, 2027, as long as he continues to serve on the Board of Directors through that date.
TEUBER WILLIAM J JR reported acquisition or exercise transactions in this Form 4 filing.
IonQ, Inc. director William J. Teuber Jr. reported receiving an award of 4,526 shares of common stock in the form of restricted stock units. These RSUs vest in full on the earlier of the day before the next year’s Annual Meeting or on June 17, 2027, assuming he continues serving on the Board. Following this grant, he holds 13,939 shares of IonQ common stock directly.
IonQ, Inc. CFO & COO Inder M. Singh reported a small share disposition to cover taxes on vested stock awards. On this Form 4, he disposed of 2,617 shares of common stock to satisfy tax liability arising from the vesting of restricted stock units. The shares were sold at a weighted average price of $59.75 per share, with individual trades executed between $58.80 and $59.77. After these transactions, Singh directly holds 414,886 IonQ common shares, indicating this was a routine tax-related event rather than a large change in ownership.
Scannell William F reported acquisition or exercise transactions in this Form 4 filing.
IonQ, Inc. director William F. Scannell received a grant of 4,526 shares of Common Stock in the form of a restricted stock unit (RSU) award at no cash cost per share. The RSUs vest in full on the earlier of the day before the following year’s Annual Meeting or June 17, 2027, if he continues serving on the Board of Directors through that date. After this award, Scannell holds 145,086 shares of IonQ common stock directly.